Chemours Responds to EPA 2015 Ruling to Regulate HFCs

WILMINGTON, Del., Aug. 9, 2017 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in titanium technologies, fluoroproducts and chemical solutions, expresses its disappointment with the decision by the U.S. Court of Appeals for the D.C. Circuit regarding EPA's Significant New Alternatives Policy (SNAP) program Rule 20. Chemours believes EPA properly used its existing authority under the Clean Air Act and followed the required process to compare the impact of alternatives on human health and the environment before changing the status of high global warming potential (GWP) alternatives to unacceptable.

In the US, CO2 Greenhouse Gas carbon credits remain in place which offer incentives to US automakers to transition to a low-GWP refrigerant. Currently, over 50% of the market has transitioned to HFO-1234yf, and we expect this transition to continue so that automakers can take advantage of the credits. Chemours supports the continued reduction of greenhouse gas emissions and the global frame-work of climate change regulations and incentives already in place. This includes the European Union MAC Directive and F-Gas Regulations, and US CO2 Greenhouse Gas carbon credits for US automakers which will continue to drive the need for low-GWP products. The company is currently reviewing the court's ruling and assessing its options which could include an appeal of this ruling.

About The Chemours Company

The Chemours Company (NYSE: CC) helps create a colorful, capable and cleaner world through the power of chemistry.  Chemours is a global leader in titanium technologies, fluoroproducts and chemical solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations.  Chemours ingredients are found in plastics and coatings, refrigeration and air conditioning, mining and general industrial manufacturing.  Our flagship products include prominent brands such as Teflon^™, Ti-Pure^™, Krytox^™, Viton^™, Opteon^™, Freon^™, and Nafion^™.  Chemours has approximately 7,000 employees and 26 manufacturing sites serving approximately 4,000 customers in North America, Latin America, Asia-Pacific and Europe.  Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.  For more information please visit chemours.com or follow Chemours on Twitter at @chemours.

Forward-Looking Statements

This press release contains forward-looking statements, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. The words "believe," "expect," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date the statements were made. These forward-looking statements address, among other things, our agreement with DuPont relating to the MDL Settlement, the outcome or resolution of any pending or future environmental liabilities, litigation and other legal proceedings or contingencies, anticipated future operating and financial performance, business plans and prospects, transformation plans, cost savings targets, plans to increase profitability and our outlook for Adjusted EBITDA and free cash flow that are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond Chemours' control. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include: whether the MDL Settlement becomes effective; the outcome of any pending or future litigation related to PFOA; the performance by DuPont of its obligations under the MDL Settlement; the terms of any final agreement between Chemours and DuPont relating to the MDL Settlement; and other risks, uncertainties and other factors discussed in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2016. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.

CONTACT:

MEDIA:  
Cynthia Salitsky  
Global Communications Leader, Fluoroproducts & Chemical Solutions  
+1.302.773.3283  
[email protected]  

INVESTORS:  
Alisha Bellezza  
Treasurer & Director of Investor Relations  
+1.302.773.2263  
[email protected]

SOURCE The Chemours Company

Related Links

http://www.chemours.com